ImageneBio (IMA) Assets Average (2021 - 2025)
ImageneBio (IMA) posted Assets Average of $156.9 million for Q4 2025, up 9.34% sequentially from $143.5 million in Q3 2025, and up 90.32% YoY from $82.5 million in Q4 2024.
ImageneBio (IMA) Assets Average (2021 - 2025) Analysis & Trends
ImageneBio has reported Assets Average for 5 years, with the latest figure at $156.9 million in Q4 2025.
- Quarterly Assets Average rose 90.32% year-over-year to $156.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $156.9 million (up 90.32% YoY) and the FY2025 annual result came in at $84.4 million, down 18.8% from the prior year.
- Assets Average improved to $156.9 million in Q4 2025 per IMA's latest filing, from $143.5 million in the prior quarter.
- Over five years, Assets Average peaked at $286.2 million in Q2 2021 and troughed at $73.4 million in Q1 2025.
- A 5-year average of $184.5 million and a median of $181.9 million in 2022 frame the typical range for Assets Average.
- The widest YoY moves for Assets Average: up 90.32% in 2025, down 59.78% in 2025.
- Over 5 years, Assets Average stood at $254.8 million in 2021, then retreated by 28.82% to $181.4 million in 2022, then increased by 12.32% to $203.7 million in 2023, then tumbled by 59.52% to $82.5 million in 2024, then jumped by 90.32% to $156.9 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $156.9 million, $143.5 million, and $128.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | 156.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 156.93 Mn |
| Sep 30, 2025 | 143.52 Mn |
| Jun 30, 2025 | 128.50 Mn |
| Mar 31, 2025 | 73.38 Mn |
| Dec 31, 2024 | 82.46 Mn |
| Sep 30, 2024 | 153.24 Mn |
| Jun 30, 2024 | 165.13 Mn |
| Mar 31, 2024 | 182.44 Mn |
| Dec 31, 2023 | 203.71 Mn |
| Sep 30, 2023 | 193.55 Mn |
| Jun 30, 2023 | 162.08 Mn |
| Mar 31, 2023 | 162.33 Mn |
| Dec 31, 2022 | 181.36 Mn |
| Sep 30, 2022 | 200.83 Mn |
| Jun 30, 2022 | 219.47 Mn |
| Mar 31, 2022 | 237.81 Mn |
| Dec 31, 2021 | 254.79 Mn |
| Sep 30, 2021 | 270.27 Mn |
| Jun 30, 2021 | 286.24 Mn |
| Mar 31, 2021 | 231.03 Mn |